DaVita Inc. (NYSE:DVA) Given Consensus Recommendation of “Hold” by Brokerages

Shares of DaVita Inc. (NYSE:DVA) have been given an average rating of “Hold” by the eight ratings firms that are presently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and one has given a buy recommendation to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $148.00.

A number of equities analysts have issued reports on the stock. Bank of America reduced their price target on shares of DaVita from $145.00 to $140.00 and set an “underperform” rating for the company in a research report on Wednesday, September 10th. UBS Group reiterated a “buy” rating on shares of DaVita in a research note on Monday. Cowen reaffirmed a “hold” rating on shares of DaVita in a report on Monday, November 3rd. Wall Street Zen downgraded DaVita from a “buy” rating to a “hold” rating in a report on Saturday, October 11th. Finally, Barclays dropped their target price on DaVita from $149.00 to $143.00 and set an “equal weight” rating on the stock in a research report on Thursday, October 30th.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in DVA. Dynamic Technology Lab Private Ltd acquired a new position in DaVita during the 1st quarter worth $364,000. Edgestream Partners L.P. purchased a new stake in shares of DaVita during the 2nd quarter worth approximately $6,375,000. Norges Bank acquired a new position in DaVita in the second quarter valued at $32,986,000. Arrowstreet Capital Limited Partnership grew its stake in DaVita by 132.1% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 264,084 shares of the company’s stock worth $37,619,000 after buying an additional 150,318 shares during the last quarter. Finally, Caxton Associates LLP acquired a new stake in shares of DaVita in the first quarter valued at approximately $513,000. 90.12% of the stock is currently owned by institutional investors and hedge funds.

DaVita Stock Down 1.7%

DVA stock opened at $118.00 on Wednesday. DaVita has a 52 week low of $113.97 and a 52 week high of $179.60. The stock has a market capitalization of $8.33 billion, a PE ratio of 12.15, a price-to-earnings-growth ratio of 0.91 and a beta of 1.00. The firm has a 50 day moving average of $121.94 and a 200 day moving average of $131.81.

DaVita (NYSE:DVA) last posted its quarterly earnings results on Wednesday, October 29th. The company reported $2.51 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.17 by ($0.66). DaVita had a negative return on equity of 13,370.89% and a net margin of 5.80%.The company had revenue of $3.42 billion during the quarter, compared to analysts’ expectations of $3.43 billion. During the same period in the prior year, the business posted $2.59 EPS. The company’s quarterly revenue was up 4.8% on a year-over-year basis. DaVita has set its FY 2025 guidance at 10.350-11.150 EPS. On average, equities research analysts expect that DaVita will post 10.76 earnings per share for the current year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.